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ABSTRACT
Introduction: In this study, we evaluated the chemical composition of a commercial sample of essential oil from Eucalyptus 
smithii R.T. Baker and its antifungal activity against Microsporum canis ATCC 32903, Microsporum gypseum ATCC 14683, 
Trichophyton mentagrophytes ATCC 9533, T. mentagrophytes ATCC 11480, T. mentagrophytes ATCC 11481, and Trichophyton 
rubrum CCT 5507. Methods: Morphological changes in these fungi after treatment with the oil were determined by scanning 
electron microscopy (SEM). The antifungal activity of the oil was determined on the basis of minimum inhibitory concentration 
(MIC) and minimum fungicidal concentration (MFC) values. Results: The compound 1,8-cineole was found to be the 
predominant component (72.2%) of the essential oil. The MIC values of the oil ranged from 62.5μg·mL−1 to >1,000μg·mL−1, and 
the MFC values of the oil ranged from 125μg·mL−1 to >1,000μg·mL−1. SEM analysis showed physical damage and morphological 
alterations in the fungi exposed to this oil. Conclusions: We demonstrated the potential of Eucalyptus smithii essential oil as a 
natural therapeutic agent for the treatment of dermatophytosis.
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The essential oils are volatile substances formed by secondary 
metabolism of plants. They have a complex chemical profi le, 
therefore there are not a specifi c cellular target, and can have 
different pharmacological properties. The genus Eucalyptus 
belongs to the Myrtaceae family, which comprises approximately 
130 genera and 4,000 species. More than 300 species of 
Eucalyptus contain volatile oils in their leaves(1). Eucalyptus 
smithii R.T. Baker is native to Australia. It belongs to the 
subgenus Symphyomyrtus, section Maidenaria, and subseries 
Viminalinae(2). It is popularly known as gully gum or gully 
peppermint. The essential oils from Eucalyptus plants possess 
biological properties such as antibacterial, antifungal, antitumor, 
and insecticidal properties, and they are used in spices, cosmetic 
formulations, and pharmaceuticals worldwide(3) (4) (5) (6) (7) (8) (9).
Several studies have shown the antimicrobial properties of 
essential oils from various species of Eucalyptus against a wide 
range of microorganisms. The essential oils from Eucalyptus 
camaldulensis, Eucalyptus globulus, Eucalyptus tereticornis, 
Eucalyptus citriodora, and Eucalyptus odorata have shown 
strong, moderate, or weak activity against bacteria and fungi, 
including dermatophytes(10) (11) (12) (13) (14).
Dermatophytes are a group of closely related fungi that 
cause dermatophytosis, which affects approximately 40% people 
worldwide and accounts for 30% of all cutaneous mycotic 
infections. The most common clinical signs are circular patches 
of alopecia with scales formation. May arise ring injuries with 
healthy central halo and follicular papules with thin crusts on 
the outskirts(15) (16). Current treatments for dermatophytosis 
include synthetic antifungal drugs, which can give rise to adverse 
reactions and resistant strains if not administered properly(17) (18) (19). 
Essential oils serve as an alternative treatment for dermatophytosis 
because most of these oils have some degree of antifungal activity 
owing to their lipophilic nature(20). The antifungal activities 
need not be ascribed to the high content of a single chemical 
compound because synergistic effects among the major and minor 
components can occur.
Studies on the chemical composition of essential oils from 
various Eucalyptus species have found 1,8-cineole to be the 
dominant compound. However, these studies have shown large 
variations in the chemical composition of essential oils from 
different species and even in those from the same species but from 
different regions, because these volatile oils are affected by non-
genetic factors such as leaf age and seasonal variations(4) (13) (21) (22) (23).
Because of the need for new therapeutic agents for the 
treatment of dermatophytosis, and due to the fact there are reports 
in the literature of various species of Eucalyptus, we decided 
to investigate the antifungal activity of the essential oil from 
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Eucalyptus smithii R.T. Baker against major dermatophytosis-
causing filamentous fungi such as Microsporum canis, 
Microsporum gypseum, Trichophyton mentagrophytes, and 
Trichophyton rubrum in vitro and determined the resultant 
micromorphological changes in these fungi by using scanning 
electron microscopy (SEM). And to the best of our knowledge, 
this is the fi rst study to test the antifungal activity of essential 
oil from E. smithii against dermatophytes.
Essential oil from Eucalyptus smithii
A commercial sample of essential oil from E. smithii (batch 
EUCCSM105) obtained by steam distillation of plant leaves was 
acquired from Laszlo Aromatologia Ltda (Belo Horizonte, MG, 
Brazil). The sample was characterized using a gas chromatograph 
(HP5890; Hewlett-Packard, Avondale, PA, USA) equipped with 
a fl ame ionization detector. The chromatographic parameters 
were BP-1 (HP) 30m × 0.25mm BP-1 column, 1-µL injection 
(1/50 split), hydrogen as the carrier gas (2mL·min–1), 250°C 
temperature of both the detector and injector, and a temperature 
gradient (60°C initially, followed by an increase of 3°C per min 
until the temperature reached 220°C) for the column. Samples 
were diluted to 0.5% (v/v) in chloroform. Peaks were identifi ed by 
calculating the retention time and by comparing these with linear 
hydrocarbon standards C10-C18 and reports in the literature(24).
Microorganisms
The test organisms comprised six dermatophyte fungi, 
namely, M. canis ATCC 32903, M. gypseum ATCC 14683, 
T. mentagrophytes ATCC 9533, T. mentagrophytes ATCC 11480, 
T. mentagrophytes ATCC 11481 (provided by the Instituto 
Nacional de Controle de Qualidade em Saúde da Fundação 
Oswaldo Cruz, Brazil), and T. rubrum CCT 5507 (kindly gifted 
by the Fundação André Tosello, Brazil).
Antifungal screening and susceptibility testing
Preliminary antifungal activity was determined using a 
concentration of 1,000μg·mL−1 (based on the percentage of the 
major component) of the essential oil from E. smithii against the 
dermatophyte isolates. The assay was performed as described in 
an earlier report(25) with some modifi cations. Fragments (2mm) 
of dermatophytes were inoculated on Sabouraud dextrose agar 
(SDA) supplemented with the essential oil from E. smithii in a 
sterile 24-well plate for cell culture, and the antifungal activity 
was examined by determining total growth inhibition.
Minimum inhibitory concentration (MIC) was determined 
according to the National Committee for the Clinical Laboratory 
Standards Institute (CLSI) guidelines for fi lamentous fungi(26), 
with adaptations described in a previous study(27). Roswell 
Park Memorial Institute medium (RPMI-1640; Sigma-
Aldrich Inc., St. Louis, MO, USA) containing L-glutamine, 
lacking sodium bicarbonate, and buffered with 0.165mol·L−1 
3-morpholinopropanesulfonic acid (JT Baker, Griesheim, 
Germany) at pH 7.0 was used as the basal medium, with or 
without oil and antifungal agents.
Seven-day-old cultures of dermatophytes maintained in 
SDA at 28°C were used to obtain conidial inoculum, which 
was prepared by adding 8mL of 0.9% sterile saline and 20µL 
of Tween-80: DMSO (1:1 v/v). The densities of the obtained 
suspension were adjusted using a spectrophotometer (Libra S12; 
Biochrom, Cambridge, UK) at a 530-nm wavelength to achieve 
a transmittance of 68-70%. The inoculum suspensions were 
diluted (1:50v/v) using RPMI test medium to obtain suspensions 
containing cell numbers ranging from 0.4 × 104 to 5.0 × 104 
colony-forming units·mL−1. The essential oil from E. smithii 
was solubilized in the culture medium and was serially diluted to 
achieve eight concentrations ranging from 7.8 to 1,000μg·mL−1. 
Ketoconazole (Janssen Cilag, Butantã, SP, Brazil) and 
terbinafi ne (Galena, Campinas, SP, Brazil) at concentrations of 
0.005-0.24μg·mL−1 and 0.03-16.0μg·mL−1, respectively, were used 
as reference drugs. These antifungal agents were chosen because 
they have standard testing protocols and because they are the most 
widely used oral antifungal drugs in clinical practice(18) (27) (28).
The microdilution plates were incubated at 28°C and were 
examined after seven days of incubation. Minimum inhibitory 
concentration was defi ned as the lowest concentration of the oil 
at which the tested microorganisms did not show visible growth.
Minimum fungicidal concentration (MFC) was determined 
using the microdilution method(20). Aliquots of 20µL from the 
wells that did not show growth in the MIC procedure were 
transferred to new 96-well plates containing 180µL of SDA. 
The plates were incubated at 28°C for seven days. The lowest 
concentration of the oil showing no visible growth in the plates 
was defi ned as the MFC.
Scanning electron microscopy
Samples for SEM were prepared as follows. Untreated control 
blocks and agar blocks treated with essential oil (1,000μg·mL−1 
concentration) or antifungal agents (ketoconazole and 
terbinafi ne; concentrations obtained from susceptibility testing) 
at 28°C for seven days were fi xed with modifi ed Karnovsky’s 
fi xative containing 2.5% (v/v) glutaraldehyde and 2.5% (v/v) 
paraformaldehyde in 0.05M sodium cacodylate buffer (pH 7.2) 
and incubated for 24h. The samples were then washed three 
times (each wash for 10 min) with the same buffer and were 
post-fi xed with 1% (w/v) osmium tetroxide for 1h. The post-
fi xed samples were given three brief washes with distilled water 
and were dehydrated using increasing concentrations of acetone 
(25-100% v/v) at every 10-min interval(29). The samples were 
then assembled in aluminum stubs with double-faced carbon 
tapes, placed on an aluminum foil sputter coated with gold 
(2mm) (FL-9496, Balzers, Fürstentum Liechtenstein), and 
observed by SEM (JSM 6390LV; Jeol, Tokyo, Japan) under 
25kw power and a work distance of 17mm.
Chromatographic analysis of the essential oil identifi ed seven 
components that accounted for 86.2% of the total oil content. 
These are represented in Figure 1 and Table 1 according to their 
elution order observed in the chromatographic profi le.
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TABLE 1 - Chemical composition of the essential oil from Eucalyptus smithii obtained by high-resolution gas chromatography.
 Kovats index Kovats index  Peak
 (calculated) (Adams, 2009) 
Constituent Percentage
1 948 939 α-pinene 3.5
2 1,016 1,026 ρ-cymene 1.1
3 1,013 1,033 1,8-cineole 72.2
4 1,078 1,098 linalool 0.7
5 1,143 1,177 terpinen-4ol 0.8
6 1,156 1,189 α-terpineol 7.5
7 1,399 1,418 β-caryophyllene 0.4
Total - - - 86.2


















FIGURE 1 - Chromatographic profi le of the essential oil of Eucalyptus smithii. Peaks lower than 0.1% were not documented. 
(1) α-pinene, (2) β-pinene, (3) ρ-cymene, (4) 1.8-cineole, (5) linalool, (6) terpinen-4-ol, (7) α-terpineol, and (8) β-caryophyllene. 
mV: millivolt; min: minutes.
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The results of this study also showed that the commercial 
sample of the essential oil from E. smithii (batch EUCCSM105) 
could inhibit the growth of the tested fungal strains (Table 2).
Lastly, SEM observations confi rmed the physical damage 
and morphological alteration that could compromise fungal cell 
viability (Figure 2).
TABLE 2 - Antifungal activity* of essential oil from Eucalyptus smithii and reference drugs.
                    Substances
          Eucalyptus smithii            ketoconazole                 terbinafi neMicroorganism
 MIC MFC MIC MFC MIC MFC
Microsporum canis ATCC 32903 500 500 0.06 0.06 0.06 0.06
Microsporum gypseum ATCC14683 1,000 - 8.00 16.0 0.12 0.12
Trichophyton mentagrophytes ATCC 9533 250 250 4.0 4.0 0.12 0.12
Trichophyton mentagrophytes ATCC 11480 - - 2.0 2.0 0.03 0.03
Trichophyton mentagrophytes ATCC 11481 125 125 0.25 0.25 0.03 0.03
Trichophyton rubrum CCT 5507 62.5 125 1.0 4.0 0.06 0.06
MIC: minimum inhibitory concentration; MFC: minimum fungicide concentration; -: not detected at any of the tested concentrations (7.8 to 1,000μg·mL-1 of oil). 
*Results expressed as µg·mL-1.
DISCUSSION
Essential oils are very complex natural mixtures and are 
characterized by two or three major components having fairly high 
concentrations. Monoterpenes, which perform several biological 
functions, are the most dominant compounds in essential oils(30). 
In the present study, monoterpenes, represented essentially by 
α-pinene (monocyclic hydrocarbon); ρ-cymene (monocyclic 
aromatic); 1.8-cineole (ether); and linalool, terpinen-4-ol, and 
α-terpineol (alcohols), were found to be the major compounds(8) (13) (22). 
β-Caryophyllene, another compound that was identifi ed, is a bicyclic 
sesquiterpene. Elassi et al.(7) showed that the major compounds 
present in the essential oils of 10 Eucalyptus species had expected 
similarities because they were obtained from plants belonging 
to the same genus, followed by a-pinene, p-cymene, borneol, 
cryptone, spathulenol, viridifl orol and limonene. Ogunwande 
et al.(22) showed that β-pinene (39.4%) and α-pinene (30.4%) 
were the dominant constituents in oil samples obtained from 
E. tereticornis Smith and Eucalyptus grandis W. Hill, 
respectively, with no detectable 1.8-cineole. 1,8-cineole, 
the predominant compound observed in the present study, 
has relatively strong antimicrobial properties against many 
important pathogens(5) (8) (30), besides low toxicity observed in 
in vitro tests(13). However, the strong antimicrobial effect of 
essential oils is mostly attributed to additive effects, and minor 
components appear to play a signifi cant role. In addition, studies 
have shown that the antimicrobial activity of essential oils differs 
among oils obtained from different Eucalyptus species(4) (5).
Most studies on the characterization of essential oils of 
Eucalyptus indicate that the samples vary characteristically 
over the sampling period. This wide variation in the chemical 
composition of the oils can be attributed to environmental 
factors and different ages of the leaves from which the oils 
are extracted(4) (13) (21) (22) (23). In the present study, the antifungal 
activity of the essential oil showed considerable variations 
against different fungal species tested in this study, with the 
best activity being against T. rubrum. It is noteworthy that the 
antifungal activity of the essential oil from E. smithii was tested 
against three strains of T. mentagrophytes and that the oil was 
inactive only against one strain, namely, T. mentagrophytes 
ATCC 11480. The variation in the effect against these three 
fungal strains might be mainly because of their origin. For 
example, T. mentagrophytes ATCC 11480 is of animal origin, 
while T. mentagrophytes ATCC 9538 and T. mentagrophytes 
ATCC 11481 are of human origin, which may result in different 
levels of resistance to the essential oil.
Elassi et al.(13) evaluated the antibacterial, antifungal, and 
antiviral activities of essential oils from eight Eucalyptus 
species. Among these eight species, essential oils from seven 
Eucalyptus species were tested against three dermatophytes 
(Trichophyton rubrum, Trichophyton soudanense, and 
M. canis). The activities of these essential oils varied 
signifi cantly with species and strains. The essential oil from 
E. odorata showed the best better antifungal activity against all 
the tested fungal strains. This essential oil contained the highest 
mean percentage of cryptone (20.9% ± 1.3%) and the lowest 
mean percentage of 1,8-cineole (4.5% ± 1.6%). Therefore, the 
authors concluded that there was no correlation between the 
amount of 1,8-cineole and high antifungal activity. However, 
essential oils from Eucalyptus sideroxylon and Eucalyptus 
bicostata, containing the highest mean percentage of 1,8-cineole 
and moderate amount of α-pinene, were less toxic and could 
inhibit the growth of M. canis.
The biological activity of essential oils varies according to 
the presence of test compounds in the oil and the dose. Moreover, 
structure–activity relationships of certain phytochemicals 
are found to be important for the biological activity of these 
essential oils. A study by Kim and Park(14) showed that aldehydes 
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FIGURE 2 - A. SEM images of Microsporum canis ATCC 32903. Magnifi cation: A1-3: 1,100×; A4: 1,500×. B. SEM images of Microsporum 
gypseum ATCC14683; magnifi cation: 1,500×. C. SEM images of Trichophyton mentagrophytes ATCC 9538; magnifi cation: 3,500×. 
D. SEM images of Trichophyton mentagrophytes ATCC 11481; magnifi cation: 1,500×. E. SEM images of Trichophyton rubrum CCT 5507; 
magnifi cation: 5,000×. E1: fungal cells not exposed to substances of interest; E2: fungal cells exposed to Eucalyptus smithii essential oil; 
arrows indicate clusters of hyphae with little vesicles on the surface, compressed and furrowed hyphae, and swollen appearance and 
alteration in the surface structure; E3: Fungal cells exposed to ketoconazole, and E4: fungal cells exposed to terbinafi ne: arrows indicate 
the appearance of dried and wrinkled hyphae. Scale bars: A, B, D = 10μm; C, E = 5μm. SEM: scanning electron microscopy.
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(neral and geranial) and alcohols (citronellol and geraniol) were 
more effective antifungal agents against Aspergillus species 
than hydrocarbons. This study also showed that the position of 
the hydroxyl group was associated with the antifungal activity.
In the present study, the MIC and MFC results were 
complemented by micromorphological results obtained using 
SEM. Scanning eletron microscopy showed that treatment of 
the fungal strains with the essential oil had a detrimental effect 
on their morphology. 
Electron micrographs of all tested fungi showed differences in 
their structures compared with those of fungi not treated with the 
E. smithii essential oil, ketoconazole, or terbinafi ne. Exposure to 
essential oil and drugs caused similar alterations in all fungi, only with 
different intensities: the fungal cells exposed to the drugs appeared 
more dehydrated and therefore more compact than exposure to oil. 
The most common changes were the compression and clustering of 
hyphae without the original tubular shape, and appearance of dried 
and wrinkled hyphae. A review of the investigated literature suggests 
that this is caused by the extravasation of cell cytoplasm. This is 
partly associated with the lipophilic nature of essential oils, which 
leads to their accumulation in membranes and subsequent energy 
depletion(5) (31) (32). Thus, we surmise that the present essential oil from 
E. smithii can modify the permeability of fungal cells, leading to 
various structural and biochemical changes and, eventually, death.
The fi ndings of the present study indicate that the essential oil 
from E. smithii (batch EUCCSM105) could be useful for inhibiting 
the growth of some dermatophytes and has potential as a natural 
therapeutic agent for the treatment of dermatophytosis.  One must 
take into account that the knowledge of Eucalyptus’s pharmacological 
activity, antifungal in particular, has been consolidated and 
increased with every new study carried out with the genu. 
However, further research is necessary to elucidate its 
mechanism of action and to develop formulations for improving 
its activity and stability for use in humans and animals. 
Moreover, large variations in the chemical compositions 
of essential oils from various Eucalyptus species and the 
subsequent effects this can have on biological activities imply 
the need for more effi cient quality control of the raw materials.
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